15 results on '"Alarcon, Ma"'
Search Results
2. Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients
- Author
-
Goldhaber, Sz, Leizorovicz, A, Kakkar, A, Haas, Sk, Merli, G, Weitz, Ji, Ceresetto, Jm, Kyrle, P, Gallus, A, Cools, F, Saraiva, J, Faucher, Jp, Chlumsky, J, Husted, S, Emmerich, J, Bauersachs, R, Zeltser, D, Prandoni, Paolo, Ghiraduzzi, A, Leiva, J, Sparby, Ja, Torbiki, A, Kobalava, Z, Jacobson, B, Suarez, C, Fu, M, Savas, I, Parkhomenko, A, Ansell, J, Landis, Jr, Elliott, Cg, Borris, Lc, Samama, Mm, Pinede, L, Becker, F, Coppere, B, Nony, P, Merah, A, Alves, M, Boulet, H, Loppinet, A, Nicol, C, Ohanessian, L, Roncato, C, Knabb, Rm, Liaw, D, Smith, K, Hess, T, Rossi, L, Chen, D, Doan, C, Doran, J, Matheis, E, Ballard, M, Tsarova, O, Levenstein, S, Tvedegaard, M, Akkal, Z, Jure, H, Mercado, Da, Zangroniz, P, Constantino, M, Bello, F, Giumelli, C, de Sagastizabal, D, Risso Patron, F, Ceresetto, J, Dran, R, Vita, N, Baratta, S, Ahuad Guerrero, R, Penchasky, D, Rubinfeld, A, Layden, M, Karrasch, J, Coughlin, P, Peters, M, Gibbs, H, Ward, Ch, Hahn, U, Pilger, E, Minar, E, El Allaf, D, Marechal, P, Motte, S, Verhamme, P, Wollaert, B, Duck, L, Freire, A, Piegas, L, Jorge, Jm, Guimaraes, H, Oliveira, M, Blacher, C, Leães, P, Toniolo, J, Okoshi, M, Rosa, Dd, Cunha, C, Lobo, S, Leader, R, Dhar, A, Tarabain, O, Miron, M, Brossoit, R, Kahn, S, Kassis, J, Douketis, J, Spencer, F, Faucher, J, Alarcon, Ma, Gutierrez Valenzuela, F, Bisbal Malig, C, Vejar, M, Jaramillo, N, Saaibi, D, Londono, D, Kolman, P, Reiterer, P, Ballek, L, Spacek, R, Soucek, M, Patek, F, Vitovec, M, Kovarova, K, Ceska, R, Podpera, I, Faber, J, Oestergaard, L, Vejby Christensen, H, Frost, L, Rasmussen, Sl, Tuxen, C, Ingerslev, J, Knudsen, T, Torp Pedersen, C, Pedersen, C, Nielsen, H, Mottier, D, Simoneau, G, Leduc, J, Lorcerie, B, Paleiron, N, Proust, A, Conri, C, Pernod, G, Mismetti, P, Achkar, A, Maignan, M, Harenberg, J, Beyer, J, Horacek, T, Lawall, H, Hecker, U, Hammerstingl, C, Weil, J, Fischer, D, Brachmann, J, Klepzig, H, Cheng, G, Soltesz, P, Schnabel, R, Futo, L, Jobbagy, L, Singh, P, Talwar, D, Bhadade, R, Bharani, A, Krishnamurthy, S, Goyal, A, Mehta, P, Samiuddin, M, D'Souza, G, Sinha, S, Sathe, P, Sethuraman, S, Jaganmani, S, Sundaram, P, Saxena, A, Mehta, M, Omar, A, Rajkumar, J, Jog, S, Kumar, S, Hayek, T, Hussein, O, Lahav, M, Efrati, S, Elias, M, Grossman, E, Lugassy, G, Porath, A, Porreca, E, Prandoni, P, Tosetto, A, Imberti, D, Pierfranceschi, G, Ghirarduzzi, A, Scannapieco, G, Testa, S, Ling, P, Yusoff, K, Yusof, Z, Lopez Rosas, E, Hernandez, I, Nanez Terreros, H, Flota, L, Campos, E, Alcocer, M, Viergever, P, Sparby, J, Cotrina, R, Salas, M, Pamo, O, Fajardo, L, Horna, M, Ulloa, V, Toce, L, Moncada, Z, Salazar, O, Habaluyas, R, Collado, F, Edmilao, M, Abola, T, Sevilla, R, Torbicki, A, Tracz, W, Kasprzak, J, Jastrzebski, D, Psuja, P, Hiczkiewicz, J, Piepiorka, M, Pulkowski, G, Tyszkiewicz, I, Kuc, K, Gordeev, I, Boyarkin, M, Privalov, D, Abrosimov, V, Reshetko, O, Goloshchekin, B, Vishnevsky, A, Boldueva, S, Kostenko, V, Mkrtchian, V, Chernichka, I, Belenkov, Y, Rodoman, G, Andreev, D, Shvarts, Y, Aleksandrov, O, Zadionchenko, V, Klochkov, O, Tay, J, Jagadesan, R, Basson, M, Siebert, R, Viljoen, J, Gray, T, Abdool Gaffar, M, Suh, G, In, K, Choi, D, Kim, S, Baek, S, Chung, H, Shin, J, Alvarez Sala, L, Cepeda, J, Ferrer, M, Mallibovsky, L, Garcia Morillo, J, Villalta, J, Gomez Cerezo, J, Capitán, F, Gonzalez Garrido, F, Guijarro, C, Jimenez, D, Richart, C, Elf, J, Ueng, K, Huang, T, Karan, A, Erten, N, Abrahamovych, O, Chopey, I, Gavrysiuk, V, Kraiz, I, Karpenko, A, Volkov, V, Denesyuk, V, Kharchenko, N, Tseluyko, V, Batushkin, V, Sushko, V, Yagensky, A, Ignatenko, G, Dziublyk, O, Cohen, A, Bareford, D, Kesteven, P, Mccollum, P, Das, S, Conrad, S, Botnick, W, Nathanson, A, Hamad, A, Fraiz, J, Goytia Leos, D, Fulmer, J, Mclaren, G, Streiff, M, Hahn, B, Ardolic, B, Klausner, H, Welch, M, Pullman, J, Phillips, D, Felt, J, Mitchell, G, Margolis, B, Pendleton, R, Mahesh, A, Barney, J, Shadan, F, Schuller, D, Joslin, S, Feldman, J, Pearl, R, Welker, J, Hazelrigg, M, Stevens, S, Siegel, M, Meade, A, Bates, J, Tahirkheli, N, Rosenberg, D, Dishman, K, Ikerd, T, Feldman, G, O'Connell, C, Vaince, U, Dabbagh, O, Eyster, E, Weinstein, G, Ginsberg, R, Fine, J, Tillinghast, A, Alabi, F, Nathan, R, Haught, H, Oliver, M., Cardiovascular Division (SZG), Brigham and Women's Hospital [Boston], Université Claude Bernard Lyon 1 (UCBL), Université de Lyon, Thrombosis Research Institute (AKK), University College of London [London] (UCL), Institute for Experimental Oncology and Therapy Research (IEOTR), Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM), Jefferson Medical College (JMC), Thomas Jefferson University Hospitals, Thrombosis and Atherosclerosis Research Institute (TARI), McMaster University [Hamilton, Ontario], Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Centre d'Investigation Clinique (CIC - Brest), and Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
Male ,MESH: Pulmonary Embolism ,Placebo-controlled study ,MESH: Hospitalization ,Kaplan-Meier Estimate ,030204 cardiovascular system & hematology ,law.invention ,MESH: Venous Thromboembolism ,chemistry.chemical_compound ,0302 clinical medicine ,MESH: Aged, 80 and over ,Randomized controlled trial ,law ,Risk Factors ,MESH: Risk Factors ,Medicine ,MESH: Double-Blind Method ,030212 general & internal medicine ,MESH: Treatment Outcome ,Aged, 80 and over ,MESH: Aged ,MESH: Middle Aged ,General Medicine ,Orvostudományok ,Venous Thromboembolism ,Middle Aged ,3. Good health ,Pulmonary embolism ,Hospitalization ,Treatment Outcome ,Acute Disease ,MESH: Acute Disease ,Apixaban ,Female ,Respiratory Insufficiency ,MESH: Hemorrhage ,medicine.drug ,Adult ,medicine.medical_specialty ,Randomization ,MESH: Enoxaparin ,Pyridones ,Medicina ,Hemorrhage ,MESH: Anticoagulants ,MESH: Drug Administration Schedule ,Klinikai orvostudományok ,Drug Administration Schedule ,03 medical and health sciences ,Double-Blind Method ,Internal medicine ,MESH: Pyridones ,Humans ,Risk factor ,Enoxaparin ,MESH: Kaplan-Meier Estimate ,Aged ,Heart Failure ,MESH: Humans ,business.industry ,Anticoagulants ,MESH: Adult ,medicine.disease ,MESH: Male ,Surgery ,chemistry ,Relative risk ,Betrixaban ,MESH: Heart Failure ,Pyrazoles ,business ,Pulmonary Embolism ,MESH: Female ,MESH: Pyrazoles ,MESH: Respiratory Insufficiency ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
The efficacy and safety of prolonging prophylaxis for venous thromboembolism in medically ill patients beyond hospital discharge remain uncertain. We hypothesized that extended prophylaxis with apixaban would be safe and more effective than short-term prophylaxis with enoxaparin. METHODS: In this double-blind, double-dummy, placebo-controlled trial, we randomly assigned acutely ill patients who had congestive heart failure or respiratory failure or other medical disorders and at least one additional risk factor for venous thromboembolism and who were hospitalized with an expected stay of at least 3 days to receive apixaban, administered orally at a dose of 2.5 mg twice daily for 30 days, or enoxaparin, administered subcutaneously at a dose of 40 mg once daily for 6 to 14 days. The primary efficacy outcome was the 30-day composite of death related to venous thromboembolism, pulmonary embolism, symptomatic deep-vein thrombosis, or asymptomatic proximal-leg deep-vein thrombosis, as detected with the use of systematic bilateral compression ultrasonography on day 30. The primary safety outcome was bleeding. All efficacy and safety outcomes were independently adjudicated. RESULTS: A total of 6528 subjects underwent randomization, 4495 of whom could be evaluated for the primary efficacy outcome - 2211 in the apixaban group and 2284 in the enoxaparin group. Among the patients who could be evaluated, 2.71% in the apixaban group (60 patients) and 3.06% in the enoxaparin group (70 patients) met the criteria for the primary efficacy outcome (relative risk with apixaban, 0.87; 95% confidence interval [CI], 0.62 to 1.23; P = 0.44). By day 30, major bleeding had occurred in 0.47% of the patients in the apixaban group (15 of 3184 patients) and in 0.19% of the patients in the enoxaparin group (6 of 3217 patients) (relative risk, 2.58; 95% CI, 1.02 to 7.24; P = 0.04). CONCLUSIONS: In medically ill patients, an extended course of thromboprophylaxis with apixaban was not superior to a shorter course with enoxaparin. Apixaban was associated with significantly more major bleeding events than was enoxaparin, Supported by Bristol-Myers Squibb and Pfizer
- Published
- 2011
- Full Text
- View/download PDF
3. Overrepresentation of Glutamate Signaling in Alzheimer's Disease: Network-Based Pathway Enrichment Using Meta-Analysis of Genome-Wide Association Studies
- Author
-
Potash, JB, Perez-Palma, E, Bustos, BI, Villaman, CF, Alarcon, MA, Avila, ME, Ugarte, GD, Reyes, AE, Opazo, C, De Ferrari, GV, Potash, JB, Perez-Palma, E, Bustos, BI, Villaman, CF, Alarcon, MA, Avila, ME, Ugarte, GD, Reyes, AE, Opazo, C, and De Ferrari, GV
- Abstract
Genome-wide association studies (GWAS) have successfully identified several risk loci for Alzheimer's disease (AD). Nonetheless, these loci do not explain the entire susceptibility of the disease, suggesting that other genetic contributions remain to be identified. Here, we performed a meta-analysis combining data of 4,569 individuals (2,540 cases and 2,029 healthy controls) derived from three publicly available GWAS in AD and replicated a broad genomic region (>248,000 bp) associated with the disease near the APOE/TOMM40 locus in chromosome 19. To detect minor effect size contributions that could help to explain the remaining genetic risk, we conducted network-based pathway analyses either by extracting gene-wise p-values (GW), defined as the single strongest association signal within a gene, or calculated a more stringent gene-based association p-value using the extended Simes (GATES) procedure. Comparison of these strategies revealed that ontological sub-networks (SNs) involved in glutamate signaling were significantly overrepresented in AD (p<2.7×10(-11), p<1.9×10(-11); GW and GATES, respectively). Notably, glutamate signaling SNs were also found to be significantly overrepresented (p<5.1×10(-8)) in the Alzheimer's disease Neuroimaging Initiative (ADNI) study, which was used as a targeted replication sample. Interestingly, components of the glutamate signaling SNs are coordinately expressed in disease-related tissues, which are tightly related to known pathological hallmarks of AD. Our findings suggest that genetic variation within glutamate signaling contributes to the remaining genetic risk of AD and support the notion that functional biological networks should be targeted in future therapies aimed to prevent or treat this devastating neurological disorder.
- Published
- 2014
4. Correlations Between Neutrophil/Lymphocyte Ratio, Platelets/Lymphocyte Ratio, and Systemic Immune-Inflammation Index and Fatigue in Systemic Lupus Erythematosus.
- Author
-
Ortiz-Nuño MF, Serna-Peña G, Garcia-Arellano G, Cardenas-de la Garza JA, Toledo-Motta JP, Villarreal-Alarcon MA, and Galarza-Delgado DA
- Published
- 2025
- Full Text
- View/download PDF
5. ColombiaTuitionSET: Labeled dataset for exploring socioeconomic status, career selection, and tuition fees at a Colombian public university.
- Author
-
Villa-Garzon FA, Muñoz-Alarcon MA, and Branch-Bedoya JW
- Abstract
This dataset examines the interplay between socioeconomic status and educational outcomes among students at the Universidad Nacional de Colombia. Collected from publicly available data in collaboration with the National Directorate of Information, the dataset includes anonymized records of 3361 students from multiple university campuses during the first semester of 2021. It captures a diverse array of socioeconomic and academic variables, such as family income, residence type, tuition fee, and career choice, providing a unique basis for studying educational access in Colombia. Following authorization from the National Directorate of Information, the dataset underwent a rigorous anonymization and validation process, ensuring data integrity and reproducibility. The data was systematically cleaned and organized to highlight key demographic and socioeconomic variables relevant to student accessibility, persistence, and financial sustainability in higher education. With its detailed structure, this dataset is a valuable resource for policymakers and researchers focused on reducing educational inequalities. It supports analyses that reveal how socioeconomic conditions impact educational pathways, enabling the design of targeted interventions to enhance equity in university access and retention. This dataset contributes significantly to the understanding of educational challenges in Colombian public universities, providing a comprehensive basis for the investigation of the socioeconomic factors that influence students' access to and success in higher education., (© 2024 The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
6. Systemic sclerosis in Hispanics: cutaneous salt and pepper lesions.
- Author
-
Ocampo-Candiani J, Suro-Santos Y, Villarreal-Martinez A, Herz-Ruelas ME, Galarza-Delgado DA, Hernandez-Galarza IJ, Villareal-Alarcon MA, Flores-Alvarado DE, Gomez-Flores M, Vazquez-Martinez OT, and Chavez-Alvarez S
- Subjects
- Hispanic or Latino, Humans, Scleroderma, Systemic
- Published
- 2022
- Full Text
- View/download PDF
7. Deletions in VANGL1 are a risk factor for antibody-mediated kidney disease.
- Author
-
Jiang SH, Mercan S, Papa I, Moldovan M, Walters GD, Koina M, Fadia M, Stanley M, Lea-Henry T, Cook A, Ellyard J, McMorran B, Sundaram M, Thomson R, Canete PF, Hoy W, Hutton H, Srivastava M, McKeon K, de la Rúa Figueroa I, Cervera R, Faria R, D'Alfonso S, Gatto M, Athanasopoulos V, Field M, Mathews J, Cho E, Andrews TD, Kitching AR, Cook MC, Riquelme MA, Bahlo M, and Vinuesa CG
- Subjects
- Adult, Aged, Animals, Biopsy, Cohort Studies, DNA Copy Number Variations genetics, Homozygote, Humans, Introns genetics, Kidney metabolism, Kidney pathology, Lupus Nephritis genetics, Membrane Proteins deficiency, Membrane Proteins metabolism, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Risk Factors, Mice, Antibodies adverse effects, Carrier Proteins genetics, Gene Deletion, Kidney Diseases pathology, Membrane Proteins genetics
- Abstract
We identify an intronic deletion in VANGL1 that predisposes to renal injury in high risk populations through a kidney-intrinsic process. Half of all SLE patients develop nephritis, yet the predisposing mechanisms to kidney damage remain poorly understood. There is limited evidence of genetic contribution to specific organ involvement in SLE.
1 , 2 We identify a large deletion in intron 7 of Van Gogh Like 1 ( VANGL1 ), which associates with nephritis in SLE patients. The same deletion occurs at increased frequency in an indigenous population (Tiwi Islanders) with 10-fold higher rates of kidney disease compared with non-indigenous populations. Vangl1 hemizygosity in mice results in spontaneous IgA and IgG deposition within the glomerular mesangium in the absence of autoimmune nephritis. Serum transfer into B cell-deficient Vangl1+/- mice results in mesangial IgG deposition indicating that Ig deposits occur in a kidney-intrinsic fashion in the absence of Vangl1 . These results suggest that Vangl1 acts in the kidney to prevent Ig deposits and its deficiency may trigger nephritis in individuals with SLE., Competing Interests: The authors declare no competing interests., (© 2021 The Author(s).)- Published
- 2021
- Full Text
- View/download PDF
8. Fundamentos de ginecología y obstetricia
- Author
-
Gli, Wilmar Saldarrlaga, Alarcón, Manuel Antonlo Artuz, Gli, Wilmar Saldarrlaga, and Alarcón, Manuel Antonlo Artuz
- Published
- 2010
- Full Text
- View/download PDF
9. Diplopia and ocular pain due to orbital myositis.
- Author
-
Arvizu-Rivera RI, Pineda-Sic RA, Cardenas-de la Garza JA, Galarza-Delgado DA, and Villarreal-Alarcon MA
- Subjects
- Diagnosis, Differential, Diplopia etiology, Humans, Pain etiology, Myositis diagnosis, Orbital Myositis complications, Orbital Myositis diagnostic imaging
- Published
- 2020
- Full Text
- View/download PDF
10. Antropología de la inhumanidad : Un ensayo interpretativo sobre el terror en Colombia.
- Author
-
ALARCÓN, MARÍA VICTORIA URIBE and ALARCÓN, MARÍA VICTORIA URIBE
- Published
- 1905
- Full Text
- View/download PDF
11. Identification of c.1531C>T Pathogenic Variant in the CDH1 Gene as a Novel Germline Mutation of Hereditary Diffuse Gastric Cancer.
- Author
-
Norero E, Alarcon MA, Hakkaart C, de Mayo T, Mellado C, Garrido M, Aguayo G, Lagos M, Torres J, Calvo A, Guilford P, and Corvalan AH
- Subjects
- Adult, Female, Gastrectomy methods, Genetic Association Studies, Humans, Male, Middle Aged, Neoplasm Staging, Neoplastic Syndromes, Hereditary diagnosis, Neoplastic Syndromes, Hereditary prevention & control, Pedigree, Prophylactic Surgical Procedures, Stomach Neoplasms diagnosis, Stomach Neoplasms prevention & control, Young Adult, Alleles, Antigens, CD genetics, Cadherins genetics, Genetic Predisposition to Disease, Germ-Line Mutation, Neoplastic Syndromes, Hereditary genetics, Stomach Neoplasms genetics
- Abstract
Germline pathogenic variants in the CDH1 gene are a well-established cause of hereditary diffuse gastric cancer (HDGC) syndrome. The aim of this study was to characterize CDH1 mutations associated with HDGC from Chile, a country with one of the highest incidence and mortality rates in the world for gastric cancer (GC). Here, we prospectively include probands with family history/early onset of diffuse-type of GC. The whole coding sequence of the CDH1 gene was sequenced from genomic DNA in all patients, and a multidisciplinary team managed each family member with a pathogenic sequence variant. Thirty-six cases were included (median age 44 years/male 50%). Twenty-seven (75%) patients had diffuse-type GC at ≤50 years of age and 19 (53%) had first or second-degree family members with a history of HDGC. Two cases (5.5%) carried a non-synonymous germline sequence variant in the CDH1 gene: (a) The c.88C>A missense variant was found in a family with three diffuse-type GC cases; and (b) c.1531C>T a nonsense pathogenic variant was identified in a 22-year-old proband with no previous family history of HDGC. Of note, six family members carry the same nonsense pathogenic variant. Prophylactic gastrectomy in the proband's sister revealed stage I signet-ring cell carcinoma. The finding of 1531C>T pathogenic variant in the CDH1 in proband with no previous family history of HDGC warrants further study to uncover familial clustering of disease in CDH1 negative patients. This finding may be particularly relevant in high incidence countries, such as the case in this report.
- Published
- 2019
- Full Text
- View/download PDF
12. The Reprimo Gene Family: A Novel Gene Lineage in Gastric Cancer with Tumor Suppressive Properties.
- Author
-
Amigo JD, Opazo JC, Jorquera R, Wichmann IA, Garcia-Bloj BA, Alarcon MA, Owen GI, and Corvalán AH
- Subjects
- Cell Proliferation genetics, Gene Expression Regulation, Neoplastic, Genes, Tumor Suppressor, Humans, Promoter Regions, Genetic, Stomach Neoplasms pathology, Cell Cycle Proteins genetics, DNA Methylation genetics, Glycoproteins genetics, Membrane Proteins genetics, Stomach Neoplasms genetics
- Abstract
The reprimo ( RPRM ) gene family is a group of single exon genes present exclusively within the vertebrate lineage. Two out of three members of this family are present in humans: RPRM and RPRM-Like ( RPRML ). RPRM induces cell cycle arrest at G2/M in response to p53 expression. Loss-of-expression of RPRM is related to increased cell proliferation and growth in gastric cancer. This evidence suggests that RPRM has tumor suppressive properties. However, the molecular mechanisms and signaling partners by which RPRM exerts its functions remain unknown. Moreover, scarce studies have attempted to characterize RPRML , and its functionality is unclear. Herein, we highlight the role of the RPRM gene family in gastric carcinogenesis, as well as its potential applications in clinical settings. In addition, we summarize the current knowledge on the phylogeny and expression patterns of this family of genes in embryonic zebrafish and adult humans. Strikingly, in both species, RPRM is expressed primarily in the digestive tract, blood vessels and central nervous system, supporting the use of zebrafish for further functional characterization of RPRM . Finally, drawing on embryonic and adult expression patterns, we address the potential relevance of RPRM and RPRML in cancer. Active investigation or analytical research in the coming years should contribute to novel translational applications of this poorly understood gene family as potential biomarkers and development of novel cancer therapies.
- Published
- 2018
- Full Text
- View/download PDF
13. Posterior reversible encephalopathy syndrome due to malignant hypercalcemia: physiopathological considerations.
- Author
-
Camara-Lemarroy CR, Gonzalez-Moreno EI, Ortiz-Corona Jde J, Yeverino-Castro SG, Sanchez-Cardenas M, Nuñez-Aguirre S, Villarreal-Alarcon MA, and Galarza-Delgado DA
- Subjects
- Adult, Breast Neoplasms diagnosis, Breast Neoplasms pathology, Carcinoma, Ductal, Breast diagnosis, Carcinoma, Ductal, Breast pathology, Female, Humans, Hypercalcemia diagnosis, Paraneoplastic Syndromes diagnosis, Posterior Leukoencephalopathy Syndrome diagnosis, Breast Neoplasms complications, Carcinoma, Ductal, Breast complications, Hypercalcemia complications, Paraneoplastic Syndromes complications, Posterior Leukoencephalopathy Syndrome etiology
- Abstract
Context: Posterior reversible encephalopathy syndrome (PRES) is a neurological entity characterized by seizures, headache, and reversible subcortical vasogenic edema. It is associated with many etiologies, most often hypertension, chronic renal failure, and chemotherapy. Hypercalcemia is rarely associated with PRES., Objective: The aim of this study is to describe and discuss a case of PRES that developed in a patient with malignant hypercalcemia, with emphasis on the possible pathophysiological mechanisms involved., Patients and Methods: A 38-year-old woman presented with altered mental status. She had a 2-month history of lumbar pain of moderate intensity, weight loss, and gastrointestinal complaints, in addition to a mass in her left breast. Her corrected serum calcium was 14.5 mg/dL. She was normotensive, had no focalizing signs, and her cerebrospinal fluid was normal. Despite treatment, her neurological state did not resolve, and she developed severe headaches at day 4 of her admission. Brain magnetic resonance imaging showed a bilateral and symmetric hyperintensity in the occipital and parietal lobes on T2-weighted and fluid-attenuated inversion recovery imaging, a characteristic highly suggestive of PRES. After correction of hypercalcemia, her symptoms and imaging abnormalities resolved., Conclusions: The development of PRES in the setting of severe hypercalcemia is extremely rare. Hypercalcemia could lead to PRES in the absence of hypertension by various mechanisms, including vasospasm, endothelial dysfunction, and an inflammatory state. A high index of suspicion is needed in this setting because hypercalcemia can lead to neurological symptomatology, and prompt diagnosis is essential for adequate treatment.
- Published
- 2014
- Full Text
- View/download PDF
14. Wnt/β-catenin signaling in Alzheimer's disease.
- Author
-
De Ferrari GV, Avila ME, Medina MA, Perez-Palma E, Bustos BI, and Alarcon MA
- Subjects
- Alzheimer Disease metabolism, Animals, Humans, Alzheimer Disease pathology, Brain metabolism, Wnt Proteins metabolism, Wnt Signaling Pathway physiology, beta Catenin metabolism
- Abstract
Alzheimer's disease is a neurodegenerative disorder that causes a progressive decline of mental and cognitive processes such as memory, judgment and reasoning. We proposed earlier that a sustained loss of function of Wnt/β- catenin signaling components underlies the onset and progression of the disease. Here, we discuss recent data on the involvement of Wnt/b-catenin signaling on amyloid precursor protein (APP) processing, Aβ peptide neurotoxicity, τ phosphorylation, and modulation of Apolipoprotein E function in the brain. We conclude that several components of the cascade are actively engaged in the events leading to AD neuropathology and propose that compounds that mimic activation of this signaling cascade, such as lithium, should be considered for therapeutic intervention in Alzheimer's patients. In summary, data accumulated during the past decade confirm some important predictions of our hypothesis where components of this signaling cascade are actively engaged in the events leading to AD neuropathology and that compounds that mimic activation of this signaling cascade, such as lithium, should be considered for therapeutic intervention in Alzheimer's patients.
- Published
- 2014
- Full Text
- View/download PDF
15. Relationship between growth of the preovulatory follicle and its steroidogenic activity on the onset and expression of estrus behavior in CIDR-treated Bos indicus cows: an observational study.
- Author
-
Diaz D, Galina CS, Fiordelisio T, Rubio I, Alarcon MA, Rodriguez AD, and Orihuela A
- Subjects
- Animals, Aromatase metabolism, Cattle, Cholesterol Side-Chain Cleavage Enzyme metabolism, Estradiol metabolism, Estrus blood, Estrus Synchronization methods, Female, Follicular Phase blood, Ovarian Follicle diagnostic imaging, Ovariectomy, Progesterone metabolism, Progesterone pharmacology, Time Factors, Ultrasonography, Estrus physiology, Follicular Phase physiology, Follicular Phase psychology, Ovarian Follicle growth & development, Ovarian Follicle metabolism, Sexual Behavior, Animal physiology
- Abstract
Estrus synchronization induces cows to gather in sexually active groups (SAGs) composed of females displaying mounting activity. Although this technique promotes the enhancement of sexual behavior, there are cows in estrus (CE) that delay estrus expression and also cows not displaying estrus (CNDE) even in the presence of a preovulatory follicle (PF). To elucidate the physiological mechanisms of the delay in the onset of estrus or absence of estrus behavior, an observational study was undertaken in 17 Bos indicus cows treated with exogenous progesterone (CIDR) to synchronize estrus and to monitor follicular growth and its steroidogenic activity. After SAGs formation, cows were ovariectomized at 24, 48, and 72 h post-CIDR. Among ovariectomized groups there were only 9 CE which: 1) showed differences in the onset of estrus; 2) displayed distinctive follicular growth patterns; and 3) at 72 h produced the highest intrafollicular estradiol concentration, and showed a linear trend to increase expression of P450scc and P450arom. Comparison of CE vs. CNDE showed that: 1) both groups had progesterone levels indicative of cyclic activity, and a PF which grew at a similar rate and size; 2) CE showed a stronger association between time and growth; and 3) CE produced more intrafollicular estradiol and progesterone, together with the expression of higher levels of P450arom. Results suggest that pending on the pattern of growth of the PF and its steroidogenic potential to produce estradiol, the onset and expression of estrus behavior may be delayed probably until the establishment of the appropriate conditions to ensure ovulation., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.